Therapeutic plasma exchange in the pediatric intensive care unit: A single-center 5-Year experience
| dc.authorid | 0000-0003-2563-2429 | |
| dc.authorid | 0000-0001-7892-2927 | |
| dc.contributor.author | Duyu, Muhterem | |
| dc.contributor.author | Turkozkan, Ceren | |
| dc.date.accessioned | 2025-05-10T19:43:47Z | |
| dc.date.issued | 2020 | |
| dc.department | İstanbul Medeniyet Üniversitesi | |
| dc.description.abstract | The objective of this study is to characterize clinical indications, safety and outcome with the use of TPE in critically ill children. All TPE procedures performed in a tertiary pediatric intensive care unit (PICU) during a 5 year period were retrospectively evaluated. A total of 75 patients underwent 249 sessions of TPE. Sepsis-induced multiple organ dysfunction syndrome (MODS) was the most common indication with 29.3 %. American Society for Apheresis classifications were as follows: Category I: 24 %, Category II: 16 %, Category III: 45.3 % and Category IV: 4%, while 10.7 % of the patients could not be classified. TPE was performed without any adjunct procedures in 188 sessions (75.5 %), while it was combined with continuous renal replacement therapy (CRRT) in 49 sessions (19.7 %) and with CRRT and extracorporeal membrane oxygenation (ECMO) in 12 (4.8 %) sessions. Overall survival rate was 73.3 %. The survival rate in patients requiring only TPE was 86.5 %, while the survival rates of patients who had CRRT and ECMO were 45 % and 33.3 %, respectively. Complications associated with the procedure occurred in 48 (19.2 %) TPE sessions. The lowest survival rate (31.9 %) was in patients with sepsis-induced MODS. Finally, we also found significantly higher organ failure rate, mechanical ventilation requirement, and PRISM III score at PICU admission in non-survivors. Our experience indicates that TPE can be performed relatively safely in critically ill children with appropriate treatment indications. Survival rate may vary depending on the underlying disease; however, it must be noted that survival rate is very high in children requiring TPE only. | |
| dc.identifier.doi | 10.1016/j.transci.2020.102959 | |
| dc.identifier.issn | 1473-0502 | |
| dc.identifier.issue | 5 | |
| dc.identifier.pmid | 33011077 | |
| dc.identifier.scopus | 2-s2.0-85092189031 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.uri | https://doi.org/10.1016/j.transci.2020.102959 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14730/10727 | |
| dc.identifier.volume | 59 | |
| dc.identifier.wos | WOS:000594183900018 | |
| dc.identifier.wosquality | Q4 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Pergamon-Elsevier Science Ltd | |
| dc.relation.ispartof | Transfusion and Apheresis Science | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WOS_20250302 | |
| dc.subject | Therapeutic plasma exchange | |
| dc.subject | Pediatric intensive care | |
| dc.subject | Indications | |
| dc.subject | Complications | |
| dc.title | Therapeutic plasma exchange in the pediatric intensive care unit: A single-center 5-Year experience | |
| dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1










